To assess metastatic capacity, we then performed tail vein injections of BAP1-deficient and control uveal melanoma cells in the same mouse strain, and the BAP1-deficient cells formed fewer metastases in the liver and lungs compared to control cells (Figure 4c-e and Additional file 2). The gene discussed is BAP1; the disease is uveal melanoma.